Medical Market Report

Global Biological Safety Testing Market By Type (Adventitious Agents Detection Test, Cell Line Authentication and Characterization tests, Bioburden Testing, Endotoxin Tests, Sterility Testing, and Residual Host Contaminant Detection Tests), By Application (Blood Products, Stem Cell Products, Cellular and Gene Therapy Products, and Tissue Products), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2020-2029

  • 135935
  • 18-Dec
  • PDF/PPT/Word
  • ★ ★ ★ ★ ★
    ★ ★ ★ ★ ★
  • Report Details

    The report on Biological Safety Testing Market offers in-depth analysis of market trends, drivers, restraints, opportunities etc. Along with qualitative information, this report includes the quantitative analysis of various segments in terms of market share, growth, opportunity analysis, market value, etc. for the forecast years. The global biological safety testing market is segmented on the basis of Type, Application, and geography.

    The Global Biological Safety Testing market is estimated to be US$ XX.X Mn in 2019 and is projected to increase significantly at a CAGR of x.x% from 2020 to 2028.

    Biological Safety Testing Market Scope:

    By type, the market is segmented into Adventitious Agents Detection Test, Cell Line Authentication and Characterization tests, Bioburden Testing, Endotoxin Tests, Sterility Testing, and Residual Host Contaminant Detection Tests. By Application, the market is divided into Blood Products, Stem Cell Products, Cellular and Gene Therapy Products, and Tissue Products.
    Based on geography, the market is analyzed across North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Major players profiled in the report include Lonza Group, SGS SA, WuXiPharmaTech, BSL Bioservice, Merck KGaA, Cytovance Biologics, Toxikon Corporation, Charles River Laboratories International, Sigma-Aldrich Corporation, and Avance Biosciences.

    Key Market Segments

    Type

    Adventitious Agents Detection Test
    Cell Line Authentication and Characterization tests
    Bioburden Testing
    Endotoxin Tests
    Sterility Testing
    Residual Host Contaminant Detection Tests

    Application

    Blood Products
    Stem Cell Products
    Cellular and Gene Therapy Products
    Tissue Products

    Key Market Players included in the report:

    Lonza Group
    SGS SA
    WuXiPharmaTech
    BSL Bioservice
    Merck KGaA
    Cytovance Biologics
    Toxikon Corporation
    Charles River Laboratories International
    Sigma-Aldrich Corporation
    Avance Biosciences

    Reasons to Get this Report:

    In an insight outlook, this research report has dedicated to several quantities of analysis – industry research (global industry trends) and Biological Safety Testing Market share analysis of high players, along with company profiles, and which collectively include about the fundamental opinions regarding the market landscape; emerging and high-growth sections of Biological Safety Testing Market; high-growth regions; and market drivers, restraints, and also market chances.
    The analysis covers Biological Safety Testing Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global Biological Safety Testing Market across sections such as also Application and representatives.
    Additionally, the analysis also has a comprehensive review of the crucial players on the Biological Safety Testing Market together side their company profiles, SWOT analysis, latest advancements, and business plans.

    The analysis objectives of the report are:

    To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers, and industry-specific challenges and risks).
    To know the Biological Safety Testing Market by pinpointing its many subsegments.
    To profile the important players and analyze their growth plans.
    To endeavor the amount and value of Biological Safety Testing sub-markets, depending on key regions (various vital states).
    To analyze Biological Safety Testing Market concerning growth trends, prospects, and also their participation in the entire sector.
    To examine and study the Biological Safety Testing Market size (volume & value) from the company, essential regions/countries, products, and Application, background information from 2014 to 2019, and also prediction to 2028.
    Primary worldwide Biological Safety Testing Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
    To examine competitive progress such as expansions, arrangements, new product launches, and acquisitions on the market.

  • Table Of Content 
    1. Biological Safety Testing Market Introduction
    

    1.1. Definition
    
1.2. Taxonomy
    
1.3. Research Scope2. Executive Summary
    

      2.1. Key Findings by Major Segments
    
  2.2. Top strategies by Major Players3. Global Biological Safety Testing Market Overview
    

    3.1. Biological Safety Testing Market Dynamics
    

        3.1.1. Drivers
    
    3.1.2. Opportunities
    
    3.1.3. Restraints
    
    3.1.4. Challenges  3.2. PESTLE Analysis
    
  3.3. Opportunity Map Analysis
    
  3.4. PORTER’S Five Forces Analysis
    
  3.5. Market Competition Scenario Analysis
    
  3.6. Product Life Cycle Analysis
    
  3.7. Opportunity Orbits
    
  3.8. Production Analysis by Region/Company
    
  3.9. Industry chain Analysis
    
  3.10. Marketing Strategy4. Global Biological Safety Testing Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
    

      4.1. Global Biological Safety Testing Market Analysis by Type: Introduction
    
  4.2. Market Size and Forecast by Region
    
  4.3. Adventitious Agents Detection Test
    

      4.4. Cell Line Authentication and Characterization tests
    

      4.5. Bioburden Testing
    

      4.6. Endotoxin Tests
    

      4.7. Sterility Testing
    

      4.8. Residual Host Contaminant Detection Tests5. Global Biological Safety Testing Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
    

      5.1. Global Biological Safety Testing Market Analysis by Application: Introduction
    
  5.2. Market Size and Forecast by Region
    
  5.3. Blood Products
    

      5.4. Stem Cell Products
    

      5.5. Cellular and Gene Therapy Products
    

      5.6. Tissue Products6. Global Biological Safety Testing Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
    

      6.1. North America
    

        6.1.1. North America Biological Safety Testing Market: Regional Trend Analysis
    

         6.1.1.1. US
    
     6.1.1.2. Canada
    
     6.1.1.3. Mexico
    

      6.2.1. Europe
    

        6.2.1. Europe Biological Safety Testing Market: Regional Trend Analysis
    

         6.2.1.1. Germany
    
     6.2.1.2. France
    
     6.2.1.3. UK
    
     6.2.1.4. Russia
    
     6.2.1.5. Italy
    
     6.2.1.6. Spain
    
     6.2.1.7. Rest of Europe
    

      6.3. Asia-Pacific
    

        6.3.1. Asia-Pacific Biological Safety Testing Market: Regional Trend Analysis
    

         6.3.1.1. China
    
     6.3.1.2. Japan
    
     6.3.1.3. Korea
    
     6.3.1.4. India
    
     6.3.1.5. Rest of Asia-Pacific
    

      6.4. Latin America
    

        6.4.1. Latin America Biological Safety Testing Market: Regional Trend Analysis
    

         6.4.1.1. Brazil
    
     6.4.1.2. Argentina
    
     6.4.1.3. Rest of Latin America
    

      6.5. Middle East and Africa
    

        6.5.1. Middle East and Africa Biological Safety Testing Market: Regional Trend Analysis
    

         6.5.1.1. GCC
    
     6.5.1.2. South Africa
    
     6.5.1.3. Israel
    
     6.5.1.4. Rest of MEA
    
7. Global Biological Safety Testing Market Competitive Landscape, Market Share Analysis, and Company Profiles
    

      7.1. Market Share Analysis
    
  7.2. Company Profiles
    
  7.3. Lonza Group
    

        7.3.1. Company Overview
    
    7.3.2. Financial Highlights
    
    7.3.3. Product Portfolio
    
    7.3.4. SWOT Analysis
    
    7.3.5. Key Strategies and Developments  7.4. SGS SA
    

        7.4.1. Company Overview
    
    7.4.2. Financial Highlights
    
    7.4.3. Product Portfolio
    
    7.4.4. SWOT Analysis
    
    7.4.5. Key Strategies and Developments  7.5. WuXiPharmaTech
    

        7.5.1. Company Overview
    
    7.5.2. Financial Highlights
    
    7.5.3. Product Portfolio
    
    7.5.4. SWOT Analysis
    
    7.5.5. Key Strategies and Developments  7.6. BSL Bioservice
    

        7.6.1. Company Overview
    
    7.6.2. Financial Highlights
    
    7.6.3. Product Portfolio
    
    7.6.4. SWOT Analysis
    
    7.6.5. Key Strategies and Developments  7.7. Merck KGaA
    

        7.7.1. Company Overview
    
    7.7.2. Financial Highlights
    
    7.7.3. Product Portfolio
    
    7.7.4. SWOT Analysis
    
    7.7.5. Key Strategies and Developments  7.8. Cytovance Biologics
    

        7.8.1. Company Overview
    
    7.8.2. Financial Highlights
    
    7.8.3. Product Portfolio
    
    7.8.4. SWOT Analysis
    
    7.8.5. Key Strategies and Developments  7.9. Toxikon Corporation
    

        7.9.1. Company Overview
    
    7.9.2. Financial Highlights
    
    7.9.3. Product Portfolio
    
    7.9.4. SWOT Analysis
    
    7.9.5. Key Strategies and Developments  7.10. Charles River Laboratories International
    

        7.10.1. Company Overview
    
    7.10.2. Financial Highlights
    
    7.10.3. Product Portfolio
    
    7.10.4. SWOT Analysis
    
    7.10.5. Key Strategies and Developments  7.11. Sigma-Aldrich Corporation
    

        7.11.1. Company Overview
    
    7.11.2. Financial Highlights
    
    7.11.3. Product Portfolio
    
    7.11.4. SWOT Analysis
    
    7.11.5. Key Strategies and Developments  7.12. Avance Biosciences
    

        7.12.1. Company Overview
    
    7.12.2. Financial Highlights
    
    7.12.3. Product Portfolio
    
    7.12.4. SWOT Analysis
    
    7.12.5. Key Strategies and Developments
    

    8. Assumptions and Acronyms
    
9. Research Methodology
    
10. Contact
  • Inquiry Before Buying

    Inquiry Form

  • Request Sample

    Request for Sample

Related Reports

Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.